Literature DB >> 9374988

Contaminants in commercial preparations of melatonin.

B L Williamson, A J Tomlinson, S Naylor, G J Gleich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9374988     DOI： 10.1016/S0025-6196(11)63555-6

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  4 in total

Review 1.  Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights.

Authors:  Daniel P Cardinali; Gregory M Brown; Seithikurippu R Pandi-Perumal
Journal:  Nat Sci Sleep       Date:  2022-10-14

Review 2.  Medication for sleep-wake disorders.

Authors:  G Stores
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

Review 3.  The Potential of Phytomelatonin as a Nutraceutical.

Authors:  Marino B Arnao; Josefa Hernández-Ruiz
Journal:  Molecules       Date:  2018-01-22       Impact factor: 4.411

Review 4.  Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements.

Authors:  Deanna M Minich; Melanie Henning; Catherine Darley; Mona Fahoum; Corey B Schuler; James Frame
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.